VEGFA and macular retinal edema: When stratifying by pathology (CNV/DME/RVO-related macular edema), the reduction of anti-VEGF injections was more relevant for those performed for macular edemas than for CNV (−79.5%, −75.7%, and −46.1%, p = 0.006, p = 0.01, and p = 0.14 for DME, RVO-related macular edema, and CNV, respectively).